Daxor/$DXR
1D1W1MYTD1Y5YMAX
Capital at risk
About Daxor
Daxor Corp is a medical instrumentation and biotechnology company focused on blood volume measurement. The company develops and markets the BVA-100 (Blood Volume Analyzer), the first diagnostic blood test cleared by the FDA offers unmatched, real-time, precise data via its rapid, hand-held, lab-based system. The company operates as a single business segment centered on the development, commercialization, and support of its proprietary blood volume analysis technology used by healthcare providers.
- Ticker
- $DXR
- Sector
- Health
- Primary listing
- NASDAQ
- Employees
- 45
- Headquarters
- Oak Ridge, United States
- Website
- www.daxor.com
Daxor Metrics
BasicAdvanced
$68M
10.90
$1.07
0.26
-
Price and volume
Market cap
$68M
Beta
0.26
52-week high
$14.76
52-week low
$8.56
Average daily volume
27K
Financial strength
Current ratio
2.883
Interest coverage (TTM)
-552.44%
Profitability
Gross margin (TTM)
100.00%
Net profit margin (TTM)
19,861.41%
Operating margin (TTM)
-5,886.94%
Management effectiveness
Return on assets (TTM)
-2.63%
Return on equity (TTM)
14.24%
Valuation
Price to earnings (TTM)
10.901
Price to revenue (TTM)
2,165.332
Price to book
1.31
Price to tangible book (TTM)
1.31
Price to free cash flow (TTM)
-8.302
Free cash flow yield (TTM)
-12.05%
Free cash flow per share (TTM)
-1.401
Growth
Revenue change (TTM)
-52.70%
Earnings per share change (TTM)
195.85%
3-year revenue growth (CAGR)
-43.87%
10-year revenue growth (CAGR)
-26.35%
3-year earnings per share growth (CAGR)
8.95%
10-year earnings per share growth (CAGR)
3.05%
Upcoming events
No upcoming events
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.